Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia.

gait hemophilia joint synovitis

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 Oct 2023
Historique:
received: 05 09 2023
revised: 17 10 2023
accepted: 17 10 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

Hemophilia is an inherited hemorrhagic disorder; its main clinical manifestations being bleeding in muscles and joints. Ankles, knees, and elbows are the most frequently affected joints, followed by shoulders and hips. The clinical signs of joint involvement are reduced mobility, swelling and walking difficulties. Bleeding episodes in patients with hemophilia are usually divided into traumatic and spontaneous, but we believe that the latter are not truly spontaneous but rather the result of joint stresses owing to motion actions that create dysfunctions starting from infancy. Pharmacological prophylaxis with factor replacement therapies or non-replacement drugs markedly reduces musculoskeletal hemorrhages. However, the onset of subclinical joint stress can be reduced only by associating this therapeutic approach with the accurate observation of the child motion patterns and restoring them if dysfunctional, thereby primarily preventing subclinical bleeding and ultimately the onset or progression of hemophilic arthropathy.

Identifiants

pubmed: 37892810
pii: jcm12206672
doi: 10.3390/jcm12206672
pmc: PMC10607901
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
N Engl J Med. 2007 Aug 9;357(6):535-44
pubmed: 17687129
Semin Thromb Hemost. 2013 Oct;39(7):723-31
pubmed: 24022804
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):206-214
pubmed: 34889393
Cardiovasc Hematol Disord Drug Targets. 2016;16(1):21-24
pubmed: 28049407
Haemophilia. 2009 Mar;15(2):509-18
pubmed: 19347991
Haemophilia. 2018 May;24 Suppl 6:44-49
pubmed: 29878659
J Thromb Haemost. 2021 Sep;19(9):2112-2121
pubmed: 34197690
Thromb Res. 2014 Nov;134 Suppl 1:S61-7
pubmed: 24726553
J Thromb Haemost. 2018 Oct;16(10):1914-1917
pubmed: 30007042
J Clin Med. 2017 Nov 22;6(11):
pubmed: 29165342

Auteurs

Elena Anna Boccalandro (EA)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy.

Samantha Pasca (S)

Biomedical Sciences Department (DSB), Padua University Hospital, 35131 Padua, Italy.

Valentina Begnozzi (V)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy.

Roberta Gualtierotti (R)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milan, Italy.

Pier Mannuccio Mannucci (PM)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy.

Classifications MeSH